| 查看: 2532 | 回复: 40 | |||
| 【有奖交流】积极回复本帖子，参与交流，就有机会分得作者 wyb35402641 的 12 个金币 ，回帖就立即获得 1 个金币，每人有 1 次机会 | |||
[交流]
contrast media & molecular imaging 征稿启事
|
|||
|
Call for papers Contrast Media & Molecular Imaging Molecular Imaging in Targeted Therapeutics With the rapid development of precision medicine, targeted therapy of tumors has made great advances. However, tumors of the same type were found to harbor different molecular alterations such as specific receptor, transporter, cell expression levels before and even during the targeted therapy. Molecular imaging allows mapping of disease markers in vivo and disease biology understanding. It promotes targeted therapy by therapeutic effect prediction, early response evaluation and therapeutic regimen determination in preclinical and clinical settings. Molecular imaging technologies are being recognized as the one of most valuable tools in the field of precision medicine, which will make individual treatment decisions for better patient outcome care. The main focus of this special issue will be on the recent advances of molecular imaging for targeted treatment strategies in precision medicine. We particularly take an interest in manuscripts that report of targeted therapeutics of molecular imaging for tumors, but not limited to tumors. This special issue accepts original research articles as well as review articles that will show a diversity of new developments in these areas. Potential topics include but are not limited to the following: Molecular imaging guided therapy in targeted chemotherapy, internal radiotherapy, and precision surgery. New advances in molecular imaging for prediction, monitoring, and early response evaluation of targeted therapy in preclinical and clinical settings. Applications in targeted therapy of malignant tumors and benign disease, such as inflammation/immune disorders, heart and brain disorders (AD, PD). Molecular imaging in passive targeted therapy such as chemoembolization, brachytherapy, drug-encapsulated implant and nanoparticle. New target spot such as specific gene, receptor, transporter, antigen and synthesized targeting probes. PET, SPECT, MR, ultrasound, fluorescence, photoacoustic and multimodal imaging. Authors can submit their manuscripts through the Manuscript Tracking System at https://mts.hindawi.com/submit/journals/cmmi/mitt/ Manuscript Due : September 29, 2017 First Round of Reviews: December 22, 2017 Publication Date: February 16, 2018 Lead Guest Editor Yuebing Wang, Nankai University, Tianjin, China wangyuebing@ nankai.edu.cn Guest Editors Zhen Cheng, Stanford University, Stanford, USA zcheng@stanford.edu Shuang Liu, Purdue University, West Lafayette, USA liu100@purdue.edu Guoqiang Shao, Nanjing First Hospital, Nanjing Medical University, Nanjing, China guoqiangshao@163.com About this Journal Contrast Media & Molecular Imaging provides an international forum for the expeditious publication of research articles, reviews, clinical studies, and letters to the editors in the booming areas of contrast media & molecular imaging. The most recent Impact Factor for Contrast Media & Molecular Imaging is 3.286 according to the 2015 Journal Citation Reports released by Thomson Reuters in 2016. The average time between submission and final decision is 47 days and the average time between acceptance and publication is 34 days. |
回复此楼» 猜你喜欢
青基如何破局
已经有4人回复
-
基金不中，共勉
已经有8人回复
-
基金未中，这种答复是模板吗？
已经有5人回复
-
为什么资助数各大高校都创新高，自己申请怎么就这么难
已经有5人回复
-
有多少人是今天查系统知道结果的？
已经有17人回复
-
导师吐槽：我怎么摊上了这么个极品研究生！
已经有5人回复
-
怎么看青基中了没有啊
已经有5人回复
-
梦想
已经有3人回复
-
面上合作单位盖章
已经有3人回复
-
看板上这么多中的，有点像50人群里49个人都是骗子的那种感觉……
已经有5人回复
» 本主题相关价值贴推荐，对您同样有帮助:
10楼2017-04-10 12:26:15
13楼2017-04-10 12:40:23
32楼2017-04-10 15:48:31
简单回复
2017-04-10 12:15
回复
wyb35402641(金币+1): 谢谢参与
jufayin3楼
2017-04-10 12:17
回复
2017-04-10 12:18
回复
wyb35402641(金币+1): 谢谢参与
。 发自小木虫IOS客户端
2017-04-10 12:19
回复
wyb35402641(金币+1): 谢谢参与
2017-04-10 12:22
回复
wyb35402641(金币+1): 谢谢参与
2017-04-10 12:23
回复
wyb35402641(金币+1): 谢谢参与
卍叶子8楼
2017-04-10 12:24
回复
wyb35402641(金币+1): 谢谢参与
顶 发自小木虫Android客户端
2017-04-10 12:25
回复
wyb35402641(金币+1): 谢谢参与
nancy_wjj11楼
2017-04-10 12:29
回复
zhaoyan197812楼
2017-04-10 12:34
回复
wyb35402641(金币+1): 谢谢参与
eiri14楼
2017-04-10 12:42
回复
bj200898915楼
2017-04-10 12:43
回复
wyb35402641(金币+1): 谢谢参与
纳米材料75316楼
2017-04-10 12:46
回复
wyb35402641(金币+1): 谢谢参与
hydzp17楼
2017-04-10 13:04
回复
wyb35402641(金币+1): 谢谢参与
xhmaohan18楼
2017-04-10 13:10
回复
tzynew19楼
2017-04-10 13:15
回复
wyb35402641(金币+1): 谢谢参与
舞动人生201220楼
2017-04-10 13:22
回复
yaoyao14521楼
2017-04-10 13:22
回复
wyb35402641(金币+1): 谢谢参与
spc0822楼
2017-04-10 13:29
回复
wyb35402641(金币+1): 谢谢参与
咯迪23楼
2017-04-10 13:45
回复
wyb35402641(金币+1): 谢谢参与
^_^ 发自小木虫IOS客户端
朝都24楼
2017-04-10 13:48
回复
wyb35402641(金币+1): 谢谢参与
好 发自小木虫Android客户端
gter_wang25楼
2017-04-10 13:48
回复
wyb35402641(金币+1): 谢谢参与
yuekong26楼
2017-04-10 13:51
回复
wyb35402641(金币+1): 谢谢参与
祝福 发自小木虫Android客户端
l41911002827楼
2017-04-10 13:55
回复
wyb35402641(金币+1): 谢谢参与
蒙蒙细雨凉28楼
2017-04-10 14:00
回复
wyb35402641(金币+1): 谢谢参与
。 发自小木虫Android客户端
龙飞哥29楼
2017-04-10 14:03
回复
wyb35402641(金币+1): 谢谢参与
祝福 发自小木虫Android客户端
frankfh30楼
2017-04-10 14:04
回复
wyb35402641(金币+1): 谢谢参与
nwuzhang31楼
2017-04-10 14:57
回复
wyb35402641(金币+1): 谢谢参与
v.cc33楼
2017-04-10 19:37
回复
wyb35402641(金币+1): 谢谢参与
158616553234楼
2017-04-10 20:07
回复
wyb35402641(金币+1): 谢谢参与
wyb3540264135楼
2017-04-12 12:35
回复
as1258936楼
2017-04-12 12:37
回复
wyb35402641(金币+1): 谢谢参与
祝福 发自小木虫Android客户端
慢步者37楼
2017-04-12 13:06
回复
wyb35402641(金币+1): 谢谢参与
^_^ 发自小木虫IOS客户端
wdxmu38楼
2017-04-12 13:13
回复
wyb35402641(金币+1): 谢谢参与
一 发自小木虫IOS客户端
坑爹马39楼
2017-04-12 13:14
回复
wyb35402641(金币+1): 谢谢参与
^_^ 发自小木虫IOS客户端
xhmaohan40楼
2017-04-12 13:41
回复
也是小白41楼
2017-04-12 14:00
回复
wyb35402641(金币+1): 谢谢参与
。 发自小木虫Android客户端
